Selective cell death of p53-insufficient cancer cells is induced by knockdown of the mRNA export molecule GANP

Apoptosis

Volumn 17, Issue 7, 2012, Pages 679-690

  Phimsen, Suchada ^a   Kuwahara, Kazuhiko ^a   Nakaya, Teruo ^a   Ohta, Kazutaka ^a   Suda, Taiji ^b   Rezano, Andri ^a   Kitabatake, Masahiro ^a   Vaeteewoottacharn, Kulthida ^c   Okada, Seiji ^c   Tone, Shigenobu ^b   Sakaguchi, Nobuo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; DNA damage; siRNA

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GERMINAL CENTER ASSOCIATED NUCLEAR PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CANCER GROWTH; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLTRANSFERASES; ANIMALS; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; DNA DAMAGE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICROSCOPY, ELECTRON; RNA TRANSPORT; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84862496690     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0711-8     Document Type: Article

References (41)

1. Méchali M (2010) Eukaryotic DNA replication origins: many choices for appropriate answers. Nat Rev Mol Cell Biol 11:728-738
2. Maslov AY, Vijg J (2009) Genome instability, cancer and aging. Biochim Biophys Acta 1790:963-969
3. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85 (Pubitemid 39050363)
4. Niida H, Nakanishi M (2006) DNA damage checkpoints in mammals. Mutagenesis 21:3-9 (Pubitemid 43288730)
5. Perez-Losada J, Mao J-H, Balmain A (2005) Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathway. Cancer Res 65:6488-6492 (Pubitemid 41060679)
6. Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739-745 (Pubitemid 350217064)
7. Rondón AG, Jimeno S, Aguilera A (2010) The interface between transcription and mRNP export: from THO to THSC/TREX-2. Biochim Biophys Acta 1799:533-538
8. Fischer T, Strässer K, Rácz A, Rodriguez-Navarro S, Oppizzi M, Ihrig P, Lechner J, Hurt E (2002) The mRNA export machinery requires the novel Sac3p-Thp1p complex to dock at the nucleoplasmic entrance of the nuclear pores. EMBO J 21:5843-5852 (Pubitemid 35315282)
9. Rodríguez-Navarro S, Fischer T, Luo MJ, Antúnez O, Brettschneider S, Lechner J, Pérez-Ortín JE, Reed R, Hurt E (2004) Sus1, a functional component of the SAGA histone acetylase complex and the nuclear pore-associated mRNA export machinery. Cell 116:75-86 (Pubitemid 38156185)
10. Gallardo M, Luna R, Erdjument-Bromage H, Tempst P, Aguilera A (2003) Nab2p and the Thp1p-Sac3p complex functionally interact at the interface between transcription and mRNA metabolism. J Biol Chem 278:24225-24232 (Pubitemid 36830259)
11. Aguilera A, Gómez-González B (2008) Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 9:204-217 (Pubitemid 351271797)
12. Kuwahara K, Yoshida M, Kondo E et al (2000) A novel nuclear phosphoprotein, GANP, is up-regulated in centrocytes of the germinal center and associated with MCM3, a protein essential for DNA replication. Blood 95:2321-2328 (Pubitemid 30167731)
13. Kuwahara K, Tomiyasu S, Fujimura S, Nomura K, Xing Y, Nishiyama N, Ogawa M, Imajoh-Ohmi S, Izuta S, Sakaguchi N (2001) Germinal center-associated nuclear protein (GANP) has a phosphorylation-dependent DNA-primase activity that is upregulated in germinal center regions. Proc Natl Acad Sci USA 98:10279-10283 (Pubitemid 32803011)
14. Kuwahara K, Fujimura S, Takahashi Y, Nakagata N, Takemori T, Aizawa S, Sakaguchi N (2004) Germinal center-associated nuclear protein contributes to affinity maturation of B cell antigen receptor in T cell-dependent responses. Proc Natl Acad Sci USA 101:1010-1015 (Pubitemid 38160575)
15. Takei Y, Swietlik M, Tanoue A, Tsujimoto G, Kouzarides T, Laskey R (2001) MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep 2:119-123 (Pubitemid 32229738)
16. Abe E, Kuwahara K, Yoshida M, Suzuki M, Terasaki H, Matsuo Y, Takahashi EI, Sakaguchi N (2000) Structure, expression, and chromosomal localization of the human gene encoding a germinal center-associated nuclear protein (GANP) that associates with MCM3 involved in the initiation of DNA replication. Gene 255:219-227
17. Bermejo R, Capra T, Jossen R et al (2011) The replication checkpoint protects fork stability by releasing transcribed genes from nuclear pores. Cell 146:233-246
18. Okamoto N, Kuwahara K, Ohta K, Kitabatake M, Takagi K, Mizuta H, Kondo E, Sakaguchi N (2010) Germinal center-associated nuclear protein (GANP) is involved in mRNA export of Shugoshin-1 required for centromere cohesion and in sister-chromatid exchange. Genes Cells 15:471-484
19. Yoshida M, Kuwahara K, Shimasaki T, Nakagata N, Matsuoka M, Sakaguchi N (2007) GANP suppresses DNA recombination measured by direct-repeat b-galactosidase gene-construct but does not suppress the type of recombination applying to immunoglobulin genes in mammalian cells. Genes Cells 12:1205-1213 (Pubitemid 47500533)
20. Bauer A, Kölling R (1996) The SAC3 gene encodes a nuclear protein required for normal progression of mitosis. J Cell Sci 109:1575-1583 (Pubitemid 26190506)
21. Ohta K, Kuwahara K, Zhang Z, Makino K, Komohara Y, Nakamura H, Kuratsu J, Sakaguchi N (2009) Decreased expression of germinal center-associated nuclear protein is involved in chromosomal instability in malignant gliomas. Cancer Sci 100:2069-2076
22. Izquierdo M (2005) Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 12:217-227
23. Degenhardt Y, Lampkin T (2010) Targeting Polo-like kinase in cancer therapy. Clin Cancer Res 16:384-389
24. Sripa B, Kaewkes S, Sithithaworn P et al (2007) Liver fluke induces cholangiocarcinoma. PLOS Med 4:e201
25. Khan SA, Thomas HC, Toledano M, Cox IJ, Taylor-Robinson SD (2005) p53 mutations in human cholangiocarcinoma: a review. Liver Int 25:704-716 (Pubitemid 41038651)
26. Chan-On W, Kuwahara K, Kobayashi N, Ohta K, Shimasaki T, Sripa B, Leelayuwat C, Sakaguchi N (2009) Cholangiocarcinomas associated with long-term inflammation express the activation-induced cytidine deaminase and germinal center-associated nuclear protein involved in immunoglobulin V-region diversification. Int J Oncol 35:287-295
27. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C, Miwa M (2005) Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11:3392-3397 (Pubitemid 40873244)
28. Ono A, Hattori S, Kariya R, Iwanaga S, Taura M, Harada H, Suzu S, Okada S (2011) Comparative study of human hematopoietic cell engraftment into Balb/c and C57BL/6 strain of Rag-2/Jak3 double-deficient mice. J Biomed Biotechnol 2011:539748
29. Kessis TD, Slebos RT, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993) Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90:3988-3992 (Pubitemid 23134151)
30. Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P, Madeo F, Kroemer G (2011) Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol 289:1-35
31. Silva MT (2010) Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 584:4491-4499
32. Shen Y, White E (2001) p53-dependent apoptosis pathways. Adv Cancer Res 82:55-84 (Pubitemid 32613382)
33. Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q (2001) Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20:2683-2690 (Pubitemid 32525299)
34. Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424-8429 (Pubitemid 36842561)
35. Pavletich NP, Chambers KA, Pabo CO (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7:2556-2564 (Pubitemid 24021012)
36. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7:2565-2574 (Pubitemid 24021013)
37. Maeda K, Singh SK, Eda K, Kitabatake M, Pham P, Goodman MF, Sakaguchi N (2010) GANP-mediated recruitment of activation-induced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. J Biol Chem 285:23945-23953
38. Rothenberg ML (1997) Topoisomerase I inhibitors: review and update. Ann Oncol 8:837-855
39. Dykxhoorn DM, Palliser D, Lieberman J (2006) The silent treatment: siRNAs as small molecule drugs. Gene Ther 13:541-552
40. Kim SS, Garg H, Joshi A, Manjunath N (2009) Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol Med 15:491-500
41. Scherr M, Morgan MA, Eder M (2003) Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 10:245-256 (Pubitemid 36131657)